Ask AI
ProCE Banner Series

Ascending to Higher Heights in the Treatment of Locally Advanced/Metastatic Bladder Cancer—Expert Insights on Navigating the Latest Guidelines and Therapeutic Advances

Join this “Experts in the Hot Seat” virtual symposium, presented in conjunction with the 2026 ASCO Genitourinary Cancers Symposium. In this roundtable, experts will explore emerging data and updated clinical guidelines for the management of locally advanced/metastatic urothelial carcinoma. Featuring interactive polling, case-based challenges, and multidisciplinary discussion, the program will explore evidence-based strategies for therapy selection, treatment sequencing, adverse event management, and aligning care with patient goals.

Not an official event of the 2026 ASCO Genitourinary Cancers Symposium. Not sponsored, endorsed, or accredited by ASCO®, Association for Clinical Oncology, or Conquer Cancer®, the ASCO Foundation.

  AMA
Who Should Attend

This activity is intended for oncologists, urologists, and other healthcare professionals who care for patients with urothelial carcinoma.

All Events

Ascending to Higher Heights in the Treatment of Locally Advanced/Metastatic Bladder Cancer—Expert Insights on Navigating the Latest Guidelines and Therapeutic Advances

Upcoming Events

February

26

2026

6:15 AM - 7:45 AM Pacific Time (PT)

Virtual

Topics

Bladder Cancer 

Additional Info

There are no fees required to participate in this activity.

Americans With Disabilities Act
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact Customer Support prior to the live event.

CME/CE Info

Goal Statement
The goal of this activity is to improve the knowledge, confidence, and competence of learners in the optimal management of patients with locally advanced/metastatic urothelial carcinoma.

Target Audience
This activity is intended for oncologists, urologists, and other healthcare professionals who care for patients with urothelial carcinoma.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Select optimal first-line therapy for patients with la/mUC based on updated guidelines, clinical data, and patient-specific factors.

  • Sequence second- and later-line therapies for patients with la/mUC using evidence-based and biomarker-informed strategies.

  • Apply multidisciplinary approaches to manage and monitor treatment-related adverse events.

  • Implement shared decision-making and caregiver engagement strategies to support personalized care for patients with la/mUC.

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC dba Decera Clinical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Physician Continuing Medical Education

Clinical Care Options, LLC dba Decera Clinical Education designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

American Board of Internal Medicine Maintenance of Certification

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.5 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

For ABIM MOC points, your information will be shared with the ABIM through Clinical Care Options, LLC dba Decera Clinical Education's Joint Accreditation Program and Activity Reporting System (JAPARS). Please allow 6-8 weeks for your MOC points to appear on your ABIM records.

By sharing your Diplomate Board ID # and DOB, you are giving Clinical Care Options, LLC dba Decera Clinical Education permission to use this information/data to report your participation to these Boards via the Joint Accreditation Program and Activity Reporting System (JA-PARS).

CME Passport

The CME credits that physicians earn from this activity will be submitted to ACCME's CME Passport, a free, centralized web application where you can create a personalized account to view, track, and generate transcripts of your reported CME credit. Visit cmepassport.org to create your account.

Disclosure of Conflicts of Interest
Decera Clinical Education requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to Decera Clinical Education policy. Decera Clinical Education is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education

Clinical Care Options, LLC dba Decera Clinical Education

Supporters

Supported by an educational grant from Pfizer Inc. and Astellas Inc.

Pfizer Inc.

Astellas Inc.

For customer support please click here.

Mailing Address:

 

Decera Clinical Education
12001 Sunrise Valley Drive
Suite 304
Reston, VA 20191